(some) Pediatrics hospital withdraw all cough syrups

Please find embedded documents from the Agha Khan Hospital in Nairobi, Kenya.
Points taken:

• Scientists says cough syrup medicine could be useless and possibly toxic to the extent of causing deaths.
  
• Questioned effectiveness of the syrup.
• Concerns that the mixtures are neither safe nor do they have any curative value.
• Johnson & Johnson, Wyeth and Novartis, voluntarily withdrew cough and cold products labelled for infants over fears that te medicines could be misadministered.
  

A review of side-effect records filed with the US Federal Drug Agency (FDA) between 1969 and 2006, found 123 reports of deaths in children associated with decongestant medicines and another drug substance commonly used to alleviate symptoms of colds and allergies.

Most of the deaths were children younger than two years. However in 2008, the FDA concluded there was enough evidence that the cough and cold medicines could be dangerous to children under two years, have no curative value, and it consequently banned over-the-counter sales of the syrups and directed manufacturers to stop production.

What is not clear yet is whether these medicines are safe for use in older children (ages two to 12), a fact the FDA is still reviewing

Two of Kenya’s top pediatrics hospital — Gertrude’s Children’s Hospital and the Aga Khan University Hospital — have announced that they are withdrawing all cough syrups from their pharmacies for children aged below 12 years. - Daily Nation (Kenya)
Click here to show/hide the Agha Khan Hospital signed documents

AKUHN Cough Syrup Medicines

Publish at Scribd or explore others:

Consensus Statement on Review of Cough & Cold Medicines

Publish at Scribd or explore others: